Baker Bros. Advisors’s Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock CYCCP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-13,253
| Closed | -$89K | – | 104 |
|
2018
Q2 | $89K | Hold |
13,253
| – | – | ﹤0.01% | 118 |
|
2018
Q1 | $77K | Hold |
13,253
| – | – | ﹤0.01% | 113 |
|
2017
Q4 | $92K | Hold |
13,253
| – | – | ﹤0.01% | 122 |
|
2017
Q3 | $98K | Hold |
13,253
| – | – | ﹤0.01% | 120 |
|
2017
Q2 | $82K | Hold |
13,253
| – | – | ﹤0.01% | 119 |
|
2017
Q1 | $83K | Hold |
13,253
| – | – | ﹤0.01% | 118 |
|
2016
Q4 | $82K | Hold |
13,253
| – | – | ﹤0.01% | 132 |
|
2016
Q3 | $90K | Hold |
13,253
| – | – | ﹤0.01% | 133 |
|
2016
Q2 | $83K | Hold |
13,253
| – | – | ﹤0.01% | 134 |
|
2016
Q1 | $76K | Hold |
13,253
| – | – | ﹤0.01% | 133 |
|
2015
Q4 | $52K | Hold |
13,253
| – | – | ﹤0.01% | 132 |
|
2015
Q3 | $62K | Hold |
13,253
| – | – | ﹤0.01% | 132 |
|
2015
Q2 | $85K | Hold |
13,253
| – | – | ﹤0.01% | 125 |
|
2015
Q1 | $86K | Hold |
13,253
| – | – | ﹤0.01% | 128 |
|
2014
Q4 | $82K | Hold |
13,253
| – | – | ﹤0.01% | 119 |
|
2014
Q3 | $103K | Hold |
13,253
| – | – | ﹤0.01% | 107 |
|
2014
Q2 | $108K | Hold |
13,253
| – | – | ﹤0.01% | 105 |
|
2014
Q1 | $113K | Sell |
13,253
-7,726
| -37% | -$65.9K | ﹤0.01% | 108 |
|
2013
Q4 | $193K | Hold |
20,979
| – | – | ﹤0.01% | 95 |
|
2013
Q3 | $177K | Hold |
20,979
| – | – | ﹤0.01% | 82 |
|
2013
Q2 | $151K | Buy |
+20,979
| New | +$151K | ﹤0.01% | 74 |
|